# CELLECT BIOTECHNOLOGY LTD (APOP)

> Institutional ownership reported to the SEC as of Q3 2021, from Form 13F filings. Source: https://holderbook.com/stocks/APOP/

- Reporting holders: 5
- Reported value: $937.0K
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [RENAISSANCE TECHNOLOGIES LLC](https://holderbook.com/funds/1037389-renaissance-technologies-llc/) | $670.0K | 36,291 | 0.0% | 1 |
| [GEODE CAPITAL MANAGEMENT, LLC](https://holderbook.com/funds/1214717-geode-capital-management-llc/) | $240.0K | 13,003 | 0.0% | 1 |
| [MORGAN STANLEY](https://holderbook.com/funds/895421-morgan-stanley/) | $22.0K | 1,213 | 0.0% | 1 |
| [JPMORGAN CHASE & CO](https://holderbook.com/funds/19617-jpmorgan-chase-co/) | $3.0K | 177 | 0.0% | 1 |
| [HUNTINGTON NATIONAL BANK](https://holderbook.com/funds/49205-huntington-national-bank/) | $2.0K | 125 | 0.0% | 1 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q3 2021 | 5 | $937.0K |
| Q3 2019 | 8 | $345.0K |
| Q2 2019 | 9 | $562.0K |
| Q1 2019 | 10 | $573.0K |
| Q4 2018 | 7 | $294.0K |

